These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18546629)

  • 1. Defective apoptosis underlies chemoresistance in ovarian cancer.
    Hajra KM; Tan L; Liu JR
    Adv Exp Med Biol; 2008; 622():197-208. PubMed ID: 18546629
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.
    Liu JR; Opipari AW; Tan L; Jiang Y; Zhang Y; Tang H; Nuñez G
    Cancer Res; 2002 Feb; 62(3):924-31. PubMed ID: 11830553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer: can we reverse drug resistance?
    Tan DS; Ang JE; Kaye SB
    Adv Exp Med Biol; 2008; 622():153-67. PubMed ID: 18546626
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic approaches to overcoming chemoresistance in ovarian cancer.
    Suh DH; Kim MK; No JH; Chung HH; Song YS
    Ann N Y Acad Sci; 2011 Jul; 1229():53-60. PubMed ID: 21793839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoresistance in ovarian cancer. State of the art and future prospects].
    Katsaros D; Fracchioli S; Arese P; Enria R; Cassinelli P; Mingrone K; Piccinno R; Rigault de la Longrais IA; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):483-99. PubMed ID: 10767997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New players in ovarian cancer.
    Bovicelli A; D'Andrilli G; Giordano A
    J Cell Physiol; 2011 Oct; 226(10):2500-4. PubMed ID: 21302305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of apaf-1 in melanoma drug resistance and apoptosis.
    Röckmann H; Schadendorf D
    J Invest Dermatol; 2005 Aug; 125(2):386-7. PubMed ID: 16098052
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells.
    Indran IR; Tufo G; Pervaiz S; Brenner C
    Biochim Biophys Acta; 2011 Jun; 1807(6):735-45. PubMed ID: 21453675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
    Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
    Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
    Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitivity and chemoresistance testing.
    Markman M
    J Clin Oncol; 2005 Oct; 23(29):7363-4. PubMed ID: 16210675
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian cancer: how can resistance to chemotherapy be tackled?
    Karakashev S; Aird KM
    Future Oncol; 2017 Dec; 13(30):2737-2739. PubMed ID: 29182383
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling.
    Yan H; Guo BY; Zhang S
    Biochem Biophys Res Commun; 2016 Feb; 470(4):947-54. PubMed ID: 26826383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    Ong PS; Chan SY; Ho PC
    Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.
    Murata T; Haisa M; Uetsuka H; Nobuhisa T; Ookawa T; Tabuchi Y; Shirakawa Y; Yamatsuji T; Matsuoka J; Nishiyama M; Tanaka N; Naomoto Y
    Int J Mol Med; 2004 Jun; 13(6):865-8. PubMed ID: 15138626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.
    Zang YS; Zhong YF; Fang Z; Li B; An J
    Cancer Gene Ther; 2012 Nov; 19(11):773-8. PubMed ID: 22996741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640.
    White MD; Chan L; Antoon JW; Beckman BS
    Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenoxodiol, a novel approach for the treatment of ovarian cancer.
    Mor G; Fu HH; Alvero AB
    Curr Opin Investig Drugs; 2006 Jun; 7(6):542-8. PubMed ID: 16784025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy.
    Miyamoto S; Yagi H; Yotsumoto F; Kawarabayashi T; Mekada E
    Adv Exp Med Biol; 2008; 622():281-95. PubMed ID: 18546636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.